SPI Medical Imaging: DeepSight’s $25m Bill for Ultrasound Disruption

Publication Date: 16/11/2021

Written by

Alan Stoddart headshot
Alan Stoddart

DeepSight Technology recently announced that it has secured $25m in Series A funding to develop its ultrasound technology, which is said to offer 100 times greater sensitivity than other options on the market. This Premium Insight weighs the vendor’s prospects and assesses what such technology means for the market.

The insight is part of Signify Research’s Premium Insight – Medical Imaging subscription service.

To view the full insight on this development hit the Request Access button above for either a complimentary one month trial or to purchase a subscription.

The Signify Research’s Premium Insight – Medical Imaging subscription service provides:

  • Approximately 100 actionable and up to the moment Premium Insights per year.
  • A subscription to Signify Premium Insights – Medical Imaging provides compelling thought leadership on the most pertinent developments in healthcare technology.
  • This service utilises Signify Research’s expansive market data to properly appraise and interpret breaking news stories.
  • Major market moves and industry-changing announcements are evaluated as they unfold, and the considered opinions of Signify Research’s expert analysts are shared to provide insight into current developments.
  • Key vendors, technologies and conferences are followed, with updates carefully scrutinised to ensure that the most important details are revealed and properly assessed.